Abbott ID NOW Controls (maxanim.com)
ABBOTT PARK, Ill., Oct.7, 2020 / PRNewswire / – In an ongoing effort to provide the facts about ID NOW to support public health interests, Abbott (NYSE: ABT) is sharing new interim clinical data results on its ID NOW Rapid COVID-19 test. The results confirm data submitted to the US Food and Drug Administration (FDA) …